Novo CEO pressed by Senate to cut charges of weight problems, diabetes prescription drugs CEO Lars Fruergaard Jørgensen instructed lawmakers the company would consider new talks with insurers with regard to the checklist price ranges of Wegovy and copyright when they pledge to maintain the medicines on their own formularies. https://edwinyqgwn.thekatyblog.com/29756483/about-healthcare-news